Altogether, these data suggest that activation of apoptotic pathway(s), such as the miR-132/SIRT1/TP53 axis, is a common feature of the response of CLL cells to BCR triggering. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.